Clinical spectrum of Hallervorden-Spatz syndrome in India

Journal of Clinical Neuroscience

Volumn 16, Issue 2, 2009, Pages 253-258

  Sachin, S ^a   Goyal, V ^a   Singh, S ^a   Shukla, G ^a   Sharma, M C ^a   Gaikwed, S ^a   Behari, M ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hallervorden Spatz syndrome; Neurodegeneration with brain iron accumulation; Pantothenate kinase associated neurodegeneration; Phenotype

Indexed keywords

ACANTHOCYTOSIS; ADOLESCENT; ADULT; APRAXIA; ARTICLE; CERVICAL DYSTONIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EYE MOVEMENT DISORDER; FEMALE; HUMAN; INDIA; MALE; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; OROMANDIBULAR DYSTONIA; PARKINSONISM; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; GLOBUS PALLIDUS; HUMANS; INDIA; MAGNETIC RESONANCE IMAGING; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58149185140     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.04.004     Document Type: Article

References (15)

1. Hayflick S.J., Westaway S.K., Levinson B., et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348 (2003) 33-40
2. Gregory A., and Hayflick S.J. Neurodegeneration with brain iron accumulation. Folia Neuropathol 43 (2005) 286-296
3. Thomas M., Hayflick S.J., and Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 19 (2004) 36-42
4. Tofaris G.K., Revesz T., Jacques T.S., et al. Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity. Arch Neurol 64 (2007) 280-282
5. Savoiardo M., Halliday W.C., Nardocci N., et al. Hallervorden-Spatz disease: MR and pathologic findings. AJNR 14 (1993) 155-162
6. Pellecchia M.T., Valente E.M., Cif L., et al. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology 64 (2005) 1810-1812
7. Swaiman K.F. Hallervorden-Spatz syndrome. Pediatr Neurol 25 (2000) 102-108
8. Bindu P.S., Desai S., Shehanaz K.E., et al. Clinical heterogeneity in Hallervorden-Spatz syndrome: a clinicoradiological study in 13 patients from South India. Brain Dev 28 (2006) 343-347
9. Dooling E.C., Schoene W.C., and Richardson Jr. E.P. Hallervorden-Spatz syndrome. Arch Neurol 30 (1974) 70-83
10. Egan R.A., Weleber R.G., Hogarth P., et al. Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). Am J Ophthalmol 140 (2005) 267-274
11. Gaytan-Garcia S., Kaufmann J.C., and Young G.B. Adult onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset: variants of the same entity? A clinico-pathological study. Clin Neuropathol 9 (1990) 136-142
12. Walker R.H., Jung H.H., Dobson-Stone C., et al. Neurologic phenotypes associated with acanthocytosis. Neurology 68 (2007) 92-98
13. Sharma M.C., Aggarwal N., Behari M., et al. Hallervorden Spatz disease: MR and pathological findings of a rare case. Neurol India 53 (2005) 102-104
14. Kapoor S., Hortnagel K., Gogia S., et al. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome). Indian J Pediatr 72 (2005) 261-263
15. Singhi P.D., and Mitra S. Hallervorden-Spatz disease: late infantile type. J Child Neurol 12 (1997) 281-282